# ZNF319

## Overview
ZNF319 is a gene that encodes the zinc finger protein 319, a member of the zinc finger protein family characterized by the presence of C2H2-type zinc finger domains. These domains are integral to the protein's function as a transcription factor, enabling it to bind specific DNA sequences and regulate gene expression. Zinc finger protein 319 is primarily active in the nucleus, where it plays a pivotal role in cellular processes such as differentiation and proliferation. The protein's ability to modulate the transcriptional landscape is crucial for maintaining cellular homeostasis and supporting organismal development. ZNF319's involvement in various cellular functions and its implications in diseases like breast cancer and type 2 diabetes highlight its significance in both biological research and potential clinical applications (Hartmann2016Nonlinear; Iacono2019Singlecell; Pont2023Applications).

## Structure
ZNF319 is a zinc finger protein characterized by the presence of C2H2-type zinc finger domains, which are crucial for its DNA-binding capability. The primary structure of ZNF319 is rich in cysteine and histidine residues, which are essential for coordinating zinc ions that stabilize the protein's structure. The secondary structure of ZNF319 likely includes alpha helices and beta sheets, common features in zinc finger proteins that facilitate the formation of the zinc finger motifs.

The tertiary structure of ZNF319 is stabilized by zinc ions, which help maintain the integrity of the zinc finger domains. These domains are critical for the protein's function, as they enable specific interactions with DNA. Zinc finger proteins, including ZNF319, can form quaternary structures through dimerization, which may influence their functional properties and interactions with other molecules.

Post-translational modifications such as phosphorylation and ubiquitination may occur in ZNF319, potentially affecting its activity, stability, and interactions. Additionally, splice variant isoforms of ZNF319 can lead to functional diversity, allowing the protein to participate in various cellular processes. These structural and functional characteristics underscore the complexity and versatility of ZNF319 as a zinc finger protein.

## Function
ZNF319, or zinc finger protein 319, functions as a transcription factor that plays a crucial role in regulating gene expression. It contains zinc finger domains, which are structural motifs that enable the protein to bind to specific DNA sequences. This binding capability allows ZNF319 to influence the transcription of target genes, thereby modulating gene activity within the cell. The protein is primarily active in the nucleus, where it exerts its regulatory functions.

In healthy human cells, ZNF319 is involved in various cellular processes, including cell differentiation and proliferation. By regulating the expression of genes associated with these processes, ZNF319 contributes to the proper development and maintenance of cellular functions. Its activity is essential for ensuring that cells differentiate into their intended types and proliferate at appropriate rates, which is vital for normal growth and tissue repair.

The precise mechanisms by which ZNF319 influences these cellular processes are linked to its ability to modulate the transcriptional landscape of the cell. Through its interactions with DNA, ZNF319 can activate or repress the expression of genes that are critical for cellular homeostasis and organismal development.

## Clinical Significance
ZNF319 has been implicated in several diseases due to its role in transcriptional regulation. In breast cancer, particularly triple-negative breast cancer (TNBC), ZNF319 has been identified as a novel metastasis suppressor gene. A study using CRISPR/Cas9 screening in a breast cancer model found that ZNF319 can halt TNBC growth and invasion both in vitro and in vivo. High expression levels of ZNF319 in breast tumor tissues are associated with better clinical outcomes, suggesting its potential as a prognostic biomarker (Pont2023Applications).

In the context of type 2 diabetes (T2D), ZNF319 has been noted for its altered gene correlations. Although the specific clinical significance in diabetes is not detailed, the inversion of gene correlations involving ZNF319 suggests its potential involvement in the disease mechanisms (Iacono2019Singlecell).

ZNF319 is also mentioned in studies related to myocardial infarction (MI). It is part of an interaction network associated with MI, indicating its potential involvement through indirect connections in large-scale co-expression networks (Hartmann2016Nonlinear).

These findings highlight the diverse roles of ZNF319 in various diseases, underscoring its importance in clinical research and potential therapeutic targeting.


## References


[1. (Hartmann2016Nonlinear) Katherine Hartmann, Michał Seweryn, Samuel K. Handleman, Grzegorz A. Rempała, and Wolfgang Sadee. Non-linear interactions between candidate genes of myocardial infarction revealed in mrna expression profiles. BMC Genomics, September 2016. URL: http://dx.doi.org/10.1186/s12864-016-3075-6, doi:10.1186/s12864-016-3075-6. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12864-016-3075-6)

[2. (Iacono2019Singlecell) Giovanni Iacono, Ramon Massoni-Badosa, and Holger Heyn. Single-cell transcriptomics unveils gene regulatory network plasticity. Genome Biology, June 2019. URL: http://dx.doi.org/10.1186/s13059-019-1713-4, doi:10.1186/s13059-019-1713-4. This article has 172 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s13059-019-1713-4)

[3. (Pont2023Applications) Mariona Pont, Marta Marqués, Maria Alba Sorolla, Eva Parisi, Izaskun Urdanibia, Serafín Morales, Antonieta Salud, and Anabel Sorolla. Applications of crispr technology to breast cancer and triple negative breast cancer research. Cancers, 15(17):4364, September 2023. URL: http://dx.doi.org/10.3390/cancers15174364, doi:10.3390/cancers15174364. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15174364)